ISDA

Deposition Date 2009-07-06

Release Date 2010-01-12

Last Version Date 2024-04-03

Entry Detail

PDB ID:

3I5Z

Keywords:

TRANSFERASE

Title:

Crystal structure of ERK2 bound to (S)-N-(2-hydroxy-1-phenylethyl)-4-(5-methyl-2-(phenylamino)pyrimidin-4-yl)-1H-pyrrole-2-carboxamide

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.20 Å

R-Value Free:

0.25

R-Value Work:

0.21

R-Value Observed:

0.21

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Mitogen-activated protein kinase 1
Gene (Uniprot):MAPK1
Chain IDs:A
Chain Length:380
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P28482 Pfam ID:PF00069 EC:2.7.11.24

Ligand Molecules

SO4

Z48

Primary Citation

Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control.

Aronov, A.M, Tang, Q, Martinez-Botella, G, Bemis, G.W, Cao, J, Chen, G, Ewing, N.P, Ford, P.J, Germann, U.A, Green, J, Hale, M.R, Jacobs, M, Janetka, J.W, Maltais, F, Markland, W, Namchuk, M.N, Nanthakumar, S, Poondru, S, Straub, J, ter Haar, E, Xie, X.Show

J.Med.Chem. 52 6362 6368 (2009)

PMID: 19827834 DOI: 10.1021/jm900630q

Abstact

The Ras/Raf/MEK/ERK signal transduction, an oncogenic pathway implicated in a variety of human cancers, is a key target in anticancer drug design. A novel series of pyrimidylpyrrole ERK inhibitors has been identified. Discovery of a conformational change for lead compound 2, when bound to ERK2 relative to antitarget GSK3, enabled structure-guided selectivity optimization, which led to the discovery of 11e, a potent, selective, and orally bioavailable inhibitor of ERK.

Legend

Protein

Chemical

Disease

Primary Citation of related structures